Nurix Therapeutics Inc Revenue per Employee (NRIX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nurix Therapeutics Inc   (NASDAQ: NRIX)
 

Nurix Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 8426.27% in the third quarter 2026, year on year to cumulative value of $702 million, Nurix Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,214,309, this marks a new company high.
Within the Healthcare sector Employees of 375 other companies have achieved higher revenue per employee. While Nurix Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 2834 to 2917. Nurix Therapeutics Inc has 317 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NRIX Revenue per Employee (Aug 31 2026)
III. Quarter		 (May 31 2026)
II. Quarter		 (Feb 28 2026)
I. Quarter		 (Nov 30 2025)
IV. Quarter		 (Aug 31 2025)
III. Quarter
Y / Y Revenue Change 8426.27 % -79.47 % -66.12 % 2.21 % -37.29 %
Sales per Employee (TTM) $ 2,214,309 115,981 226,432 264,921 263,997
NRIX's Total Ranking # 2917 # 2834 # 48 # 140 # 14
Seq. Revenue Change 7342.93 % 44.64 % -53.95 % 71.99 % -82.08 %

NRIX Company Profile >> Back to NRIX Efficiency Comparisons >> Compare NRIX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 146
Healthcare Sector # 376
Overall Market # 2917

Revenue per Employee Statistics
High Average Low
$ 2,214,309 $ 239,723 $ 12,886
(Aug 31 2026)   (Aug 31 2020)



Financial Statements
Nurix Therapeutics Inc 's Revenue MRQ $ 673 Millions Visit NRIX's Income Statement
Nurix Therapeutics Inc 's Revenues TTM $ 702 Millions Visit NRIX's aggregate revenue growth
What are NRIX's Sales? Visit NRIX's Sales by Segment




Other Ratios
Nurix Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NRIX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NRIX's Competitors
Revenue per Employee for NRIX's Suppliers
Revenue per Employee for NRIX's Customers

You may also want to know
NRIX's Sales Growth Rates NRIX's Pe Price to earnings ratio NRIX's Receivables Turnover Ratio NRIX's Stock Quote
NRIX's Net Income Growth Rates NRIX's Ps Price to Sales ratio NRIX's Sales per Employee NRIX's Asset Turnover Ratio
NRIX's Net Margin NRIX's Pb Price to Book ratio NRIX's Financial Strength Ratios NRIX's Dividend Payout Ratio
Date modified: 2026-10-14T16:57:13+00:00




Companies with similar Revenue per Employee for 12 months ending Aug 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Aug 31 2026Number of Employees Aug 31 2026
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.